Terumo Corporation (TRUMY)
TRUMY Stock Price Chart
Explore Terumo Corporation interactive price chart. Choose custom timeframes to analyze TRUMY price movements and trends.
TRUMY Company Profile
Discover essential business fundamentals and corporate details for Terumo Corporation (TRUMY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
5 Jan 2010
Employees
30.21K
Website
https://www.terumo.co.jpCEO
Hikaru Samejima
Description
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
TRUMY Financial Timeline
Browse a chronological timeline of Terumo Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 6 Nov 2025
Earnings released on 7 Aug 2025
EPS came in at $0.20 surpassing the estimated $0.17 by +20.77%, while revenue for the quarter reached $1.76B , missing expectations by -2.11%.
Earnings released on 14 May 2025
EPS came in at $0.08 falling short of the estimated $0.15 by -44.98%, while revenue for the quarter reached $1.81B , beating expectations by +1.25%.
Earnings released on 13 Feb 2025
EPS came in at $0.16 falling short of the estimated $0.16 by -2.85%, while revenue for the quarter reached $1.73B , beating expectations by +3.28%.
Earnings released on 7 Nov 2024
EPS came in at $0.13 falling short of the estimated $0.15 by -13.51%, while revenue for the quarter reached $1.64B , missing expectations by -3.51%.
Dividend declared on 30 Sept 2024
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 18 Dec 2024.
Earnings released on 8 Aug 2024
EPS came in at $0.15 surpassing the estimated $0.13 by +12.11%, while revenue for the quarter reached $1.61B , beating expectations by +4.10%.
Earnings released on 3 Jun 2024
EPS came in at $0.12 falling short of the estimated $0.12 by -5.09%, while revenue for the quarter reached $1.57B , beating expectations by +4.84%.
Stock split effective on 9 Apr 2024
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 27 Mar 2024
A dividend of $0.19 per share was announced, adjusted to $0.05. The dividend was paid on 12 Jul 2024.
Earnings released on 7 Feb 2024
EPS came in at $0.14 surpassing the estimated $0.14 by +3.55%, while revenue for the quarter reached $1.71B , beating expectations by +10.15%.
Earnings released on 14 Nov 2023
EPS came in at $0.13 surpassing the estimated $0.11 by +22.18%, while revenue for the quarter reached $1.53B , beating expectations by +3.59%.
Dividend declared on 28 Sept 2023
A dividend of $0.60 per share was announced, adjusted to $0.15. The dividend was paid on 19 Dec 2023.
Earnings released on 9 Aug 2023
EPS came in at $0.11 falling short of the estimated $0.13 by -13.25%, while revenue for the quarter reached $1.49B , missing expectations by -1.78%.
Earnings released on 15 May 2023
EPS came in at $0.10 falling short of the estimated $0.12 by -17.42%, while revenue for the quarter reached $1.53B , beating expectations by +3.93%.
Dividend declared on 30 Mar 2023
A dividend of $0.58 per share was announced, adjusted to $0.15. The dividend was paid on 13 Jul 2023.
Earnings released on 9 Feb 2023
EPS came in at $0.14 surpassing the estimated $0.14 by +2.64%, while revenue for the quarter reached $1.66B , beating expectations by +6.79%.
Earnings released on 10 Nov 2022
EPS came in at $0.09 falling short of the estimated $0.13 by -31.35%, while revenue for the quarter reached $1.42B , beating expectations by +2.09%.
Dividend declared on 29 Sept 2022
A dividend of $0.56 per share was announced, adjusted to $0.14. The dividend was paid on 20 Dec 2022.
Earnings released on 9 Aug 2022
EPS came in at $0.12 surpassing the estimated $0.11 by +7.82%, while revenue for the quarter reached $1.45B , beating expectations by +3.19%.
Earnings released on 12 May 2022
EPS came in at $0.09 falling short of the estimated $0.11 by -15.81%, while revenue for the quarter reached $1.47B , missing expectations by -1.98%.
Dividend declared on 29 Mar 2022
A dividend of $0.53 per share was announced, adjusted to $0.13. The dividend was paid on 8 Jul 2022.
Earnings released on 9 Feb 2022
EPS came in at $0.13 falling short of the estimated $0.32 by -59.48%, while revenue for the quarter reached $1.55B , missing expectations by -0.29%.
Earnings released on 4 Nov 2021
EPS came in at $0.14 , while revenue for the quarter reached $1.55B .
Dividend declared on 28 Sept 2021
A dividend of $0.57 per share was announced, adjusted to $0.14. The dividend was paid on 20 Dec 2021.
Earnings released on 4 Aug 2021
EPS came in at $0.17 , while revenue for the quarter reached $1.55B .
Earnings released on 12 May 2021
EPS came in at $0.12 , while revenue for the quarter reached $1.49B .
Dividend declared on 29 Mar 2021
A dividend of $0.54 per share was announced, adjusted to $0.14. The dividend was paid on 8 Jul 2021.
Earnings released on 4 Feb 2021
EPS came in at $0.17 , while revenue for the quarter reached $1.60B .
Earnings released on 5 Nov 2020
EPS came in at $0.11 , while revenue for the quarter reached $1.44B .
Dividend declared on 28 Sept 2020
A dividend of $0.53 per share was announced, adjusted to $0.13. The dividend was paid on 17 Dec 2020.
TRUMY Stock Performance
Access detailed TRUMY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.